Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 04, 2021

SELL
$3.17 - $4.15 $78,498 - $102,766
-24,763 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$3.77 - $5.24 $23,505 - $32,671
6,235 Added 33.65%
24,763 $104,000
Q1 2021

May 13, 2021

SELL
$4.86 - $13.07 $8,718 - $23,447
-1,794 Reduced 8.83%
18,528 $92,000
Q4 2020

Feb 16, 2021

BUY
$9.48 - $12.84 $54,671 - $74,048
5,767 Added 39.62%
20,322 $257,000
Q3 2020

Nov 12, 2020

BUY
$8.67 - $10.82 $12,051 - $15,039
1,390 Added 10.56%
14,555 $143,000
Q2 2020

Aug 13, 2020

BUY
$7.8 - $11.52 $26,254 - $38,776
3,366 Added 34.35%
13,165 $131,000
Q1 2020

May 14, 2020

BUY
$5.98 - $13.09 $7,983 - $17,475
1,335 Added 15.77%
9,799 $87,000
Q4 2019

Feb 14, 2020

SELL
$5.71 - $9.22 $53,839 - $86,935
-9,429 Reduced 52.7%
8,464 $78,000
Q3 2019

Nov 14, 2019

SELL
$5.88 - $12.35 $68,249 - $143,346
-11,607 Reduced 39.35%
17,893 $104,000
Q2 2019

Aug 14, 2019

SELL
$9.44 - $13.12 $514,640 - $715,263
-54,517 Reduced 64.89%
29,500 $352,000
Q1 2019

May 15, 2019

BUY
$12.07 - $17.54 $594,061 - $863,283
49,218 Added 141.44%
84,017 $1.01 Million
Q4 2018

Feb 14, 2019

SELL
$11.25 - $16.17 $721,102 - $1.04 Million
-64,098 Reduced 64.81%
34,799 $436,000
Q3 2018

Dec 21, 2021

BUY
$12.82 - $17.88 $364,164 - $507,899
28,406 Added 40.3%
98,897 $1.47 Million
Q3 2018

Nov 14, 2018

BUY
$12.82 - $17.88 $2,358 - $3,289
184 Added 0.26%
70,491 $1.04 Million
Q2 2018

Apr 21, 2020

BUY
$16.83 - $21.66 $496,266 - $638,688
29,487 Added 72.24%
70,307 $1.18 Million
Q2 2018

Aug 14, 2018

BUY
$16.83 - $21.66 $163,150 - $209,972
9,694 Added 31.14%
40,820 $686,000
Q1 2018

Oct 18, 2019

BUY
$19.24 - $28.03 $177,604 - $258,744
9,231 Added 42.16%
31,126 $711,000
Q1 2018

May 15, 2018

SELL
$19.24 - $28.03 $815,506 - $1.19 Million
-42,386 Reduced 65.94%
21,895 $500,000
Q4 2017

Feb 14, 2018

BUY
$13.96 - $29.05 $604,035 - $1.26 Million
43,269 Added 205.93%
64,281 $1.66 Million
Q3 2017

Nov 14, 2017

BUY
$13.91 - $15.31 $292,276 - $321,693
21,012
21,012 $309,000

Others Institutions Holding CNCE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About CONCERT PHARMACEUTICALS, INC.


  • Ticker CNCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,934,600
  • Description
  • Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...
More about CNCE
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.